Searchable abstracts of presentations at key conferences in endocrinology

ea0020p391 | Diabetes and Cardiovascular | ECE2009

Visfatin seems not to be related in insulin resistance

Taslipinar Abdullah , Taslipinar Mine Y , Azal Omer , Kebapcilar Levent , Sahin Mustafa , Uckaya Gokhan , Sonmez Y Alper , Kucukerdonmez Ozge , Kutlu Mustafa

Visfatin is a newly discovered adipocyte hormone. Recent studies showed a possible relationship between diabetes mellitus and visfatin level. But the effect of visfatin on the insulin resistance was not well understood. The aim of the present study was to explore the relation of visfatin with insulin resistance in patients with prediabetes and diabetes.We included a total of 128 persons in the study and of these 128 persons, 36 were diabetic, 69 were pre...

ea0020p369 | Diabetes and Cardiovascular | ECE2009

Epicardial adipose tissue thickness and serum visfatin levels in patients with new diagnosed prediabetes and type 2 diabetes mellitus

Taslipinar Abdullah , Taslipinar Mine Y , Azal Omer , Sahin Mustafa , Kebapcilar Levent , Ozdemir Levent , Savashan Cagatay , Uckaya Gokhan , Koz Cem , Yaman Halil , Acikel Cengizhan , Kutlu Mustafa

The relation between obesity and diabetes mellitus is known for long periods and this relation is based on insulin resistance. Recent studies showed that epicardial adipose tissue thickness measured by echocardiography is the marker of the visceral adipose tissue and cardiovascular risk. Visfatin is a new described adipokine and it has been showed to have mRNA expression in epicardial adipose tissue. There is a conflict about the role of visfatin on obesity, insulin resistance...